Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
354 hedge funds and large institutions have $5.9B invested in Amedisys in 2020 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 110 increasing their positions, 134 reducing their positions, and 45 closing their positions.
53% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 45
10% more capital invested
Capital invested by funds: $5.35B → $5.9B (+$554M)
7% more funds holding
Funds holding: 332 → 354 (+22)
1.58% more ownership
Funds ownership: 90.24% → 91.82% (+1.6%)
17% less call options, than puts
Call options by funds: $37.7M | Put options by funds: $45.5M
18% less repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 134
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$110M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$67.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$65.3M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$46.1M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$43.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$90.3M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$47.3M |
| 3 |
State Street
Boston,
Massachusetts
|
-$44.4M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$34.8M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$32M |
AMED Hedge Fund Activity: Q2 2020 in Review
354 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2020, worth a combined $5.9B — up 10% from $5.35B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new AMED positions and 45 closed out — a net gain of 24 holders — while 110 added to existing stakes and 134 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $110M. The largest seller was BlackRock, cutting an estimated $90.3M.
- 354 institutional investors held Amedisys (AMED) as of Q2 2020, up from 332 in Q1 2020.
- Funds reported $5.9B of Amedisys stock for Q2 2020, up 10% quarter-over-quarter.
- 69 funds opened new Amedisys positions in Q2 2020 and 45 closed out, a net change of +24 holders.
- The largest Amedisys buyer in Q2 2020 was Acadian Asset Management, an estimated $110M added.
- The largest Amedisys seller in Q2 2020 was BlackRock, an estimated $90.3M sold.
Based on aggregated 13F filings for Q2 2020.